Mathilde Liberge

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Infection, Anti-microbiens, Modélisation, Evolution(Current)

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Hôpital Lariboisière

Inserm

Mathilde Liberge is an author at Infection, Anti-microbiens, Modélisation, Evolution specializing in antimicrobial resistance genomics, life sciences, and antibiotic therapy for gonorrhea.

Publications per year

2023–2023

Publications

Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023

Clara Maubaret, François Caméléna, Manel Mrimèche et al. · Eurosurveillance · 2023 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Early-Onset Infection Caused by <i>Escherichia coli</i> Sequence Type 1193 in Late Preterm and Full-Term Neonates

Célie Malaure, Guillaume Geslain, André Birgy et al. · Emerging infectious diseases · 2023 · 13 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In vitro activity of apramycin against 16S-RMTase-producing Gram-negative isolates

François Caméléna, Mathilde Liberge, Inès Rezzoug et al. · Journal of Global Antimicrobial Resistance · 2023 · 11 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +16

1–3 of 3